Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study

Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance treatment and inhalation technique present with symptom control, exacerbations, and health-related quality of life (HRQoL) in child...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 15; p. 1340255
Main Authors Lizano-Barrantes, Catalina, Garin, Olatz, Mayoral, Karina, Dima, Alexandra L., Pont, Angels, Caballero-Rabasco, María Araceli, Praena-Crespo, Manuel, Valdesoiro-Navarrete, Laura, Guerra, María Teresa, Bercedo-Sanz, Alberto, Ferrer, Montse
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 13.03.2024
Subjects
Online AccessGet full text
ISSN1663-9812
1663-9812
DOI10.3389/fphar.2024.1340255

Cover

Abstract Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance treatment and inhalation technique present with symptom control, exacerbations, and health-related quality of life (HRQoL) in children and adolescents with asthma. Methods: Participants (6–14 years old) from the ARCA (Asthma Research in Children and Adolescents) cohort—a prospective, multicenter, observational study (NCT04480242)—were followed for a period from 6 months to 5 years via computer-assisted telephone interviews and a smartphone application. The Medication Intake Survey–Asthma (MIS-A) was administered to assess the implementation stage of adherence, and the Inhalation Technique Questionnaire (InTeQ) was used to assess the five key steps when using an inhaler. Symptom control was measured with the Asthma Control Questionnaire (ACQ), and HRQL was measured with the EQ-5D and the Patient-Reported Outcomes Measurement Information System–Pediatric Asthma Impact Scale (PROMIS-PAIS). Multilevel longitudinal mixed models were constructed separately with symptom control, exacerbation occurrence, EQ-5D, and PROMIS-PAIS as the dependent variables. Results: Of the 360 participants enrolled, 303 (1,203 interviews) were included in the symptom control and exacerbation analyses, 265 (732) in the EQ-5D, and 215 (617) in the PROMIS-PAIS. Around 60% of participants were male subjects, and most of them underwent maintenance treatment with inhaled corticosteroids plus long-acting β-agonists in a fixed dose (73.3%). Within-person variability was 83.6% for asthma control, 98.6% for exacerbations, 36.4% for EQ-5D, and 49.1% for PROMIS-PAIS. At the within-person level, patients with higher adherence had better symptom control ( p = 0.002) and HRQoL over time ( p = 0.016). Patients with a better inhalation technique reported worse HRQoL simultaneously ( p = 0.012), but they showed better HRQoL in future assessments ( p = 0.012). The frequency of reliever use was associated with symptom control ( p < 0.001), exacerbation occurrence ( p < 0.001), and HRQoL ( p = 0.042); and boys were more likely to present better symptom control and HRQoL than girls. Conclusion: Our results confirm longitudinal associations at the within-person level of the two indicators of quality use of inhalers: for adherence to maintenance treatment with symptom control and HRQoL, and for the inhalation technique with HRQoL. Although treatment adherence was shown to be excellent, a third of the participants reported a suboptimal inhalation technique, highlighting the need for actions for improving asthma management of the pediatric population.
AbstractList We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance treatment and inhalation technique present with symptom control, exacerbations, and health-related quality of life (HRQoL) in children and adolescents with asthma. Participants (6-14 years old) from the ARCA (Asthma Research in Children and Adolescents) cohort-a prospective, multicenter, observational study (NCT04480242)-were followed for a period from 6 months to 5 years via computer-assisted telephone interviews and a smartphone application. The Medication Intake Survey-Asthma (MIS-A) was administered to assess the implementation stage of adherence, and the Inhalation Technique Questionnaire (InTeQ) was used to assess the five key steps when using an inhaler. Symptom control was measured with the Asthma Control Questionnaire (ACQ), and HRQL was measured with the EQ-5D and the Patient-Reported Outcomes Measurement Information System-Pediatric Asthma Impact Scale (PROMIS-PAIS). Multilevel longitudinal mixed models were constructed separately with symptom control, exacerbation occurrence, EQ-5D, and PROMIS-PAIS as the dependent variables. Of the 360 participants enrolled, 303 (1,203 interviews) were included in the symptom control and exacerbation analyses, 265 (732) in the EQ-5D, and 215 (617) in the PROMIS-PAIS. Around 60% of participants were male subjects, and most of them underwent maintenance treatment with inhaled corticosteroids plus long-acting β-agonists in a fixed dose (73.3%). Within-person variability was 83.6% for asthma control, 98.6% for exacerbations, 36.4% for EQ-5D, and 49.1% for PROMIS-PAIS. At the within-person level, patients with higher adherence had better symptom control ( = 0.002) and HRQoL over time ( = 0.016). Patients with a better inhalation technique reported worse HRQoL simultaneously ( = 0.012), but they showed better HRQoL in future assessments ( = 0.012). The frequency of reliever use was associated with symptom control ( < 0.001), exacerbation occurrence ( < 0.001), and HRQoL ( = 0.042); and boys were more likely to present better symptom control and HRQoL than girls. Our results confirm longitudinal associations at the within-person level of the two indicators of quality use of inhalers: for adherence to maintenance treatment with symptom control and HRQoL, and for the inhalation technique with HRQoL. Although treatment adherence was shown to be excellent, a third of the participants reported a suboptimal inhalation technique, highlighting the need for actions for improving asthma management of the pediatric population.
Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance treatment and inhalation technique present with symptom control, exacerbations, and health-related quality of life (HRQoL) in children and adolescents with asthma.Methods: Participants (6–14 years old) from the ARCA (Asthma Research in Children and Adolescents) cohort—a prospective, multicenter, observational study (NCT04480242)—were followed for a period from 6 months to 5 years via computer-assisted telephone interviews and a smartphone application. The Medication Intake Survey–Asthma (MIS-A) was administered to assess the implementation stage of adherence, and the Inhalation Technique Questionnaire (InTeQ) was used to assess the five key steps when using an inhaler. Symptom control was measured with the Asthma Control Questionnaire (ACQ), and HRQL was measured with the EQ-5D and the Patient-Reported Outcomes Measurement Information System–Pediatric Asthma Impact Scale (PROMIS-PAIS). Multilevel longitudinal mixed models were constructed separately with symptom control, exacerbation occurrence, EQ-5D, and PROMIS-PAIS as the dependent variables.Results: Of the 360 participants enrolled, 303 (1,203 interviews) were included in the symptom control and exacerbation analyses, 265 (732) in the EQ-5D, and 215 (617) in the PROMIS-PAIS. Around 60% of participants were male subjects, and most of them underwent maintenance treatment with inhaled corticosteroids plus long-acting β-agonists in a fixed dose (73.3%). Within-person variability was 83.6% for asthma control, 98.6% for exacerbations, 36.4% for EQ-5D, and 49.1% for PROMIS-PAIS. At the within-person level, patients with higher adherence had better symptom control (p = 0.002) and HRQoL over time (p = 0.016). Patients with a better inhalation technique reported worse HRQoL simultaneously (p = 0.012), but they showed better HRQoL in future assessments (p = 0.012). The frequency of reliever use was associated with symptom control (p < 0.001), exacerbation occurrence (p < 0.001), and HRQoL (p = 0.042); and boys were more likely to present better symptom control and HRQoL than girls.Conclusion: Our results confirm longitudinal associations at the within-person level of the two indicators of quality use of inhalers: for adherence to maintenance treatment with symptom control and HRQoL, and for the inhalation technique with HRQoL. Although treatment adherence was shown to be excellent, a third of the participants reported a suboptimal inhalation technique, highlighting the need for actions for improving asthma management of the pediatric population.
Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance treatment and inhalation technique present with symptom control, exacerbations, and health-related quality of life (HRQoL) in children and adolescents with asthma. Methods: Participants (6-14 years old) from the ARCA (Asthma Research in Children and Adolescents) cohort-a prospective, multicenter, observational study (NCT04480242)-were followed for a period from 6 months to 5 years via computer-assisted telephone interviews and a smartphone application. The Medication Intake Survey-Asthma (MIS-A) was administered to assess the implementation stage of adherence, and the Inhalation Technique Questionnaire (InTeQ) was used to assess the five key steps when using an inhaler. Symptom control was measured with the Asthma Control Questionnaire (ACQ), and HRQL was measured with the EQ-5D and the Patient-Reported Outcomes Measurement Information System-Pediatric Asthma Impact Scale (PROMIS-PAIS). Multilevel longitudinal mixed models were constructed separately with symptom control, exacerbation occurrence, EQ-5D, and PROMIS-PAIS as the dependent variables. Results: Of the 360 participants enrolled, 303 (1,203 interviews) were included in the symptom control and exacerbation analyses, 265 (732) in the EQ-5D, and 215 (617) in the PROMIS-PAIS. Around 60% of participants were male subjects, and most of them underwent maintenance treatment with inhaled corticosteroids plus long-acting β-agonists in a fixed dose (73.3%). Within-person variability was 83.6% for asthma control, 98.6% for exacerbations, 36.4% for EQ-5D, and 49.1% for PROMIS-PAIS. At the within-person level, patients with higher adherence had better symptom control (p = 0.002) and HRQoL over time (p = 0.016). Patients with a better inhalation technique reported worse HRQoL simultaneously (p = 0.012), but they showed better HRQoL in future assessments (p = 0.012). The frequency of reliever use was associated with symptom control (p < 0.001), exacerbation occurrence (p < 0.001), and HRQoL (p = 0.042); and boys were more likely to present better symptom control and HRQoL than girls. Conclusion: Our results confirm longitudinal associations at the within-person level of the two indicators of quality use of inhalers: for adherence to maintenance treatment with symptom control and HRQoL, and for the inhalation technique with HRQoL. Although treatment adherence was shown to be excellent, a third of the participants reported a suboptimal inhalation technique, highlighting the need for actions for improving asthma management of the pediatric population.Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance treatment and inhalation technique present with symptom control, exacerbations, and health-related quality of life (HRQoL) in children and adolescents with asthma. Methods: Participants (6-14 years old) from the ARCA (Asthma Research in Children and Adolescents) cohort-a prospective, multicenter, observational study (NCT04480242)-were followed for a period from 6 months to 5 years via computer-assisted telephone interviews and a smartphone application. The Medication Intake Survey-Asthma (MIS-A) was administered to assess the implementation stage of adherence, and the Inhalation Technique Questionnaire (InTeQ) was used to assess the five key steps when using an inhaler. Symptom control was measured with the Asthma Control Questionnaire (ACQ), and HRQL was measured with the EQ-5D and the Patient-Reported Outcomes Measurement Information System-Pediatric Asthma Impact Scale (PROMIS-PAIS). Multilevel longitudinal mixed models were constructed separately with symptom control, exacerbation occurrence, EQ-5D, and PROMIS-PAIS as the dependent variables. Results: Of the 360 participants enrolled, 303 (1,203 interviews) were included in the symptom control and exacerbation analyses, 265 (732) in the EQ-5D, and 215 (617) in the PROMIS-PAIS. Around 60% of participants were male subjects, and most of them underwent maintenance treatment with inhaled corticosteroids plus long-acting β-agonists in a fixed dose (73.3%). Within-person variability was 83.6% for asthma control, 98.6% for exacerbations, 36.4% for EQ-5D, and 49.1% for PROMIS-PAIS. At the within-person level, patients with higher adherence had better symptom control (p = 0.002) and HRQoL over time (p = 0.016). Patients with a better inhalation technique reported worse HRQoL simultaneously (p = 0.012), but they showed better HRQoL in future assessments (p = 0.012). The frequency of reliever use was associated with symptom control (p < 0.001), exacerbation occurrence (p < 0.001), and HRQoL (p = 0.042); and boys were more likely to present better symptom control and HRQoL than girls. Conclusion: Our results confirm longitudinal associations at the within-person level of the two indicators of quality use of inhalers: for adherence to maintenance treatment with symptom control and HRQoL, and for the inhalation technique with HRQoL. Although treatment adherence was shown to be excellent, a third of the participants reported a suboptimal inhalation technique, highlighting the need for actions for improving asthma management of the pediatric population.
Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance treatment and inhalation technique present with symptom control, exacerbations, and health-related quality of life (HRQoL) in children and adolescents with asthma. Methods: Participants (6–14 years old) from the ARCA (Asthma Research in Children and Adolescents) cohort—a prospective, multicenter, observational study (NCT04480242)—were followed for a period from 6 months to 5 years via computer-assisted telephone interviews and a smartphone application. The Medication Intake Survey–Asthma (MIS-A) was administered to assess the implementation stage of adherence, and the Inhalation Technique Questionnaire (InTeQ) was used to assess the five key steps when using an inhaler. Symptom control was measured with the Asthma Control Questionnaire (ACQ), and HRQL was measured with the EQ-5D and the Patient-Reported Outcomes Measurement Information System–Pediatric Asthma Impact Scale (PROMIS-PAIS). Multilevel longitudinal mixed models were constructed separately with symptom control, exacerbation occurrence, EQ-5D, and PROMIS-PAIS as the dependent variables. Results: Of the 360 participants enrolled, 303 (1,203 interviews) were included in the symptom control and exacerbation analyses, 265 (732) in the EQ-5D, and 215 (617) in the PROMIS-PAIS. Around 60% of participants were male subjects, and most of them underwent maintenance treatment with inhaled corticosteroids plus long-acting β-agonists in a fixed dose (73.3%). Within-person variability was 83.6% for asthma control, 98.6% for exacerbations, 36.4% for EQ-5D, and 49.1% for PROMIS-PAIS. At the within-person level, patients with higher adherence had better symptom control (p = 0.002) and HRQoL over time (p = 0.016). Patients with a better inhalation technique reported worse HRQoL simultaneously (p = 0.012), but they showed better HRQoL in future assessments (p = 0.012). The frequency of reliever use was associated with symptom control (p < 0.001), exacerbation occurrence (p < 0.001), and HRQoL (p = 0.042); and boys were more likely to present better symptom control and HRQoL than girls. Conclusion: Our results confirm longitudinal associations at the within-person level of the two indicators of quality use of inhalers: for adherence to maintenance treatment with symptom control and HRQoL, and for the inhalation technique with HRQoL. Although treatment adherence was shown to be excellent, a third of the participants reported a suboptimal inhalation technique, highlighting the need for actions for improving asthma management of the pediatric population.
Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance treatment and inhalation technique present with symptom control, exacerbations, and health-related quality of life (HRQoL) in children and adolescents with asthma. Methods: Participants (6–14 years old) from the ARCA (Asthma Research in Children and Adolescents) cohort—a prospective, multicenter, observational study (NCT04480242)—were followed for a period from 6 months to 5 years via computer-assisted telephone interviews and a smartphone application. The Medication Intake Survey–Asthma (MIS-A) was administered to assess the implementation stage of adherence, and the Inhalation Technique Questionnaire (InTeQ) was used to assess the five key steps when using an inhaler. Symptom control was measured with the Asthma Control Questionnaire (ACQ), and HRQL was measured with the EQ-5D and the Patient-Reported Outcomes Measurement Information System–Pediatric Asthma Impact Scale (PROMIS-PAIS). Multilevel longitudinal mixed models were constructed separately with symptom control, exacerbation occurrence, EQ-5D, and PROMIS-PAIS as the dependent variables. Results: Of the 360 participants enrolled, 303 (1,203 interviews) were included in the symptom control and exacerbation analyses, 265 (732) in the EQ-5D, and 215 (617) in the PROMIS-PAIS. Around 60% of participants were male subjects, and most of them underwent maintenance treatment with inhaled corticosteroids plus long-acting β-agonists in a fixed dose (73.3%). Within-person variability was 83.6% for asthma control, 98.6% for exacerbations, 36.4% for EQ-5D, and 49.1% for PROMIS-PAIS. At the within-person level, patients with higher adherence had better symptom control ( p = 0.002) and HRQoL over time ( p = 0.016). Patients with a better inhalation technique reported worse HRQoL simultaneously ( p = 0.012), but they showed better HRQoL in future assessments ( p = 0.012). The frequency of reliever use was associated with symptom control ( p < 0.001), exacerbation occurrence ( p < 0.001), and HRQoL ( p = 0.042); and boys were more likely to present better symptom control and HRQoL than girls. Conclusion: Our results confirm longitudinal associations at the within-person level of the two indicators of quality use of inhalers: for adherence to maintenance treatment with symptom control and HRQoL, and for the inhalation technique with HRQoL. Although treatment adherence was shown to be excellent, a third of the participants reported a suboptimal inhalation technique, highlighting the need for actions for improving asthma management of the pediatric population.
Author Caballero-Rabasco, María Araceli
Valdesoiro-Navarrete, Laura
Dima, Alexandra L.
Garin, Olatz
Lizano-Barrantes, Catalina
Ferrer, Montse
Guerra, María Teresa
Pont, Angels
Praena-Crespo, Manuel
Mayoral, Karina
Bercedo-Sanz, Alberto
AuthorAffiliation 13 Centro de Salud Los Castros, Servicio Cántabro de Salud, Santander , Cantabria , Spain
4 Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública CIBERESP , Madrid , Spain
11 Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA) , Universitat Autònoma de Barcelona , Sabadell , Spain
6 Health Technology Assessment in Primary Care and Mental Health (PRISMA), Institut de Recerca Sant Joan de Déu , Esplugues de Llobregat , Spain
7 Pediatric Allergy and Pulmonology Unit , Pediatric Service , Hospital del Mar , Barcelona , Spain
5 National Heart and Lung Institute , Imperial College London , London , United Kingdom
10 Pediatric Allergy and Pulmonology Unit , Pediatric Service , Hospital Universitari Parc Taulí , Sabadell , Spain
8 Centro de Salud La Candelaria , Servicio Andaluz de Salud , Seville , Spain
9 Grupo de Vías Respiratorias de la Asociación Española de Pediatras de Atención Primaria (AEPAP) , Madrid , Spain
1 Health Services Research Group , Hospital del Mar Resea
AuthorAffiliation_xml – name: 2 Department of Medicine and Life Sciences , Universitat Pompeu Fabra , Barcelona , Spain
– name: 3 Department of Pharmaceutical Care and Clinical Pharmacy , Faculty of Pharmacy , Universidad de Costa Rica , San Jose , Costa Rica
– name: 5 National Heart and Lung Institute , Imperial College London , London , United Kingdom
– name: 7 Pediatric Allergy and Pulmonology Unit , Pediatric Service , Hospital del Mar , Barcelona , Spain
– name: 12 Centro de Salud Jerez Sur, Servicio Andaluz de Salud , Cadiz , Spain
– name: 11 Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA) , Universitat Autònoma de Barcelona , Sabadell , Spain
– name: 13 Centro de Salud Los Castros, Servicio Cántabro de Salud, Santander , Cantabria , Spain
– name: 4 Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública CIBERESP , Madrid , Spain
– name: 10 Pediatric Allergy and Pulmonology Unit , Pediatric Service , Hospital Universitari Parc Taulí , Sabadell , Spain
– name: 8 Centro de Salud La Candelaria , Servicio Andaluz de Salud , Seville , Spain
– name: 6 Health Technology Assessment in Primary Care and Mental Health (PRISMA), Institut de Recerca Sant Joan de Déu , Esplugues de Llobregat , Spain
– name: 9 Grupo de Vías Respiratorias de la Asociación Española de Pediatras de Atención Primaria (AEPAP) , Madrid , Spain
– name: 1 Health Services Research Group , Hospital del Mar Research Institute , Barcelona , Spain
Author_xml – sequence: 1
  givenname: Catalina
  surname: Lizano-Barrantes
  fullname: Lizano-Barrantes, Catalina
– sequence: 2
  givenname: Olatz
  surname: Garin
  fullname: Garin, Olatz
– sequence: 3
  givenname: Karina
  surname: Mayoral
  fullname: Mayoral, Karina
– sequence: 4
  givenname: Alexandra L.
  surname: Dima
  fullname: Dima, Alexandra L.
– sequence: 5
  givenname: Angels
  surname: Pont
  fullname: Pont, Angels
– sequence: 6
  givenname: María Araceli
  surname: Caballero-Rabasco
  fullname: Caballero-Rabasco, María Araceli
– sequence: 7
  givenname: Manuel
  surname: Praena-Crespo
  fullname: Praena-Crespo, Manuel
– sequence: 8
  givenname: Laura
  surname: Valdesoiro-Navarrete
  fullname: Valdesoiro-Navarrete, Laura
– sequence: 9
  givenname: María Teresa
  surname: Guerra
  fullname: Guerra, María Teresa
– sequence: 10
  givenname: Alberto
  surname: Bercedo-Sanz
  fullname: Bercedo-Sanz, Alberto
– sequence: 11
  givenname: Montse
  surname: Ferrer
  fullname: Ferrer, Montse
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38549668$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v3CAQhq0qVZOm-QM9VBx72S0GzJpeqirqR6RIvbRnNAvDmsgGF3Cl_PuwH6mSHgoHBpj3eTUwr5uzEAM2zduWrjnv1Qc3D5DWjDKxbrmgrOteNBetlHyl-padPYnPm6uc72gdXCkuxavmnPedUFL2F81yM81gComOlIRQJgyFgB0wYTBIIFjiwwAjFB8DKWiG4H8vSOoGchkmIHEpJk6Y94gZrYeSvCFzFVRU_kiAjDHsfFmsDzCSXIP7N81LB2PGq9N62fz6-uXn9ffV7Y9vN9efb1dGSFVWqlYlnbKwAcawpU5aigK5Y61zkgvEbWctKpQo6Qa2ou8c7Slaa6HOjl82N0eujXCn5-QnSPc6gteHg5h2GlLxZkTNJWedpWJjJBOsR3Bd9bRsC62TrLWV9enImpfthNbU6hKMz6DPb4If9C7-0S1VG6mErIT3J0KK9Q1z0ZPPBscRAsYla04Z66SiLaup756a_XV5_Lia0B8TTIo5J3Ta-HL4pOrtx2qq922iD22i922iT21Spewf6SP9P6IHRQPFCw
CitedBy_id crossref_primary_10_3389_fphar_2024_1340255
crossref_primary_10_18093_0869_0189_2024_34_4_506_514
crossref_primary_10_3389_fmicb_2024_1492783
Cites_doi 10.1007/s11136-020-02706-z
10.1016/S1081-1206(10)60808-3
10.1183/23120541.00140-2022
10.1016/j.jaci.2011.09.011
10.1016/s0895-4356(02)00537-1
10.1007/s11136-010-9648-y
10.1586/14737167.2015.1008459
10.1016/j.rmed.2004.10.008
10.3390/ijerph19052591
10.1016/j.jaip.2016.05.019
10.1016/S2213-2600(22)00534-3
10.1002/1099-1557(200007/08)9:4<293::AID-PDS502>3.0.CO;2-S
10.1080/08870446.2017.1290248
10.1080/02770900802627294
10.1007/s12519-023-00695-w
10.3109/02770909909087287
10.1111/j.1524-4733.2005.04054.x
10.1016/j.jaip.2016.03.002
10.1016/j.acap.2016.04.006
10.1038/s41533-018-0110-x
10.1111/j.1752-699X.2010.00218.x
10.1056/NEJMp1002074
10.4104/pcrj.2012.00061
10.1016/j.rmed.2022.106949
10.1016/j.anpedi.2013.11.028
10.4187/respcare.02478
10.3389/fped.2018.00232
10.1186/s12931-017-0710-y
10.1371/journal.pone.0202624
10.1016/S0140-6736(20)31861-4
10.1111/j.1365-2125.2012.04167.x
10.1186/s12890-022-02049-0
10.1016/j.jaip.2022.02.002
10.3389/fphar.2024.1340255
10.1185/03007990802557344
10.1002/14651858.cd002738.pub2
10.3109/02770900009055478
10.1016/j.jaip.2016.04.020
10.1089/pai.2006.024
10.1002/ppul.23498
10.1038/s41533-022-00310-x
10.1016/j.jaip.2018.03.008
10.7189/jogh.12.04052
10.1038/npjpcrm.2015.46
10.1016/j.japh.2020.02.010
10.1002/ppul.25263
10.1093/acprof:oso/9780195152968.001.0001
10.1016/S0140-6736(03)12891-7
10.3109/02770900903497196
10.1007/s40273-020-00909-3
10.1016/j.jval.2017.10.023
10.1016/j.pulmoe.2023.07.004
10.1016/j.prrv.2017.03.014
10.1164/rccm.201810-1931CI
10.1183/09031936.00075614
10.1016/S0140-6736(21)01450-1
10.1164/rccm.200801-060ST
10.1371/journal.pone.0039130
10.1016/j.rmed.2011.07.004
10.1183/16000617.0067-2021
10.1111/cea.12827
10.1111/all.14258
10.1038/s41533-017-0031-0
10.3389/fped.2022.823399
10.1016/j.drudis.2011.09.005
10.1007/s11136-010-9649-x
10.1164/ajrccm.164.8.2104102
10.3109/02770900903229651
10.1093/jpepsy/jsp074
10.1183/13993003.00901-2019
10.1016/j.pec.2008.10.001
10.1007/s40266-020-00779-6
10.1016/j.jaip.2019.09.003
10.1016/j.jaip.2016.09.022
10.1016/j.jaip.2022.02.047
10.3109/02770900903426997
10.4187/respcare.03200
10.2147/PPA.S135895
10.1016/S2214-109X(22)00506-X
10.1080/02770900701815834
10.2146/ajhp060256
10.2165/11586660-000000000-00000
10.1016/j.rmed.2005.08.012
10.1007/s11136-015-0945-3
10.1016/j.anpede.2021.10.005
10.1590/s1806-37132008001200003
10.1016/j.jaip.2017.04.006
10.1111/j.1398-9995.2008.01877.x
10.1016/j.jaci.2011.10.030
ContentType Journal Article
Copyright Copyright © 2024 Lizano-Barrantes, Garin, Mayoral, Dima, Pont, Caballero-Rabasco, Praena-Crespo, Valdesoiro-Navarrete, Guerra, Bercedo-Sanz and Ferrer.
Copyright © 2024 Lizano-Barrantes, Garin, Mayoral, Dima, Pont, Caballero-Rabasco, Praena-Crespo, Valdesoiro-Navarrete, Guerra, Bercedo-Sanz and Ferrer. 2024 Lizano-Barrantes, Garin, Mayoral, Dima, Pont, Caballero-Rabasco, Praena-Crespo, Valdesoiro-Navarrete, Guerra, Bercedo-Sanz and Ferrer
Copyright_xml – notice: Copyright © 2024 Lizano-Barrantes, Garin, Mayoral, Dima, Pont, Caballero-Rabasco, Praena-Crespo, Valdesoiro-Navarrete, Guerra, Bercedo-Sanz and Ferrer.
– notice: Copyright © 2024 Lizano-Barrantes, Garin, Mayoral, Dima, Pont, Caballero-Rabasco, Praena-Crespo, Valdesoiro-Navarrete, Guerra, Bercedo-Sanz and Ferrer. 2024 Lizano-Barrantes, Garin, Mayoral, Dima, Pont, Caballero-Rabasco, Praena-Crespo, Valdesoiro-Navarrete, Guerra, Bercedo-Sanz and Ferrer
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fphar.2024.1340255
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Lizano-Barrantes et al
EISSN 1663-9812
ExternalDocumentID oai_doaj_org_article_36325d047c62428eaf522ed2ba1f621d
PMC10976946
38549668
10_3389_fphar_2024_1340255
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
ACXDI
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c469t-92556f9da7a22e10f6d0e4e3f21ff634eeb5dde9e6e607ab485f080edddadad53
IEDL.DBID M48
ISSN 1663-9812
IngestDate Wed Aug 27 01:28:26 EDT 2025
Tue Sep 30 17:09:43 EDT 2025
Fri Sep 05 13:59:21 EDT 2025
Thu Apr 03 07:10:43 EDT 2025
Thu Apr 24 22:56:53 EDT 2025
Wed Oct 01 03:34:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords asthma exacerbations
asthma outcomes
inhalation technique
asthma symptom control
adherence
health-related quality of life
pediatric asthma
Language English
License Copyright © 2024 Lizano-Barrantes, Garin, Mayoral, Dima, Pont, Caballero-Rabasco, Praena-Crespo, Valdesoiro-Navarrete, Guerra, Bercedo-Sanz and Ferrer.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c469t-92556f9da7a22e10f6d0e4e3f21ff634eeb5dde9e6e607ab485f080edddadad53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Paolo Montuschi, Catholic University of the Sacred Heart, Italy
Jaime Correia de Sousa, University of Minho, Portugal
Reviewed by: Alvaro Teijeiro, Pediatric Hospital of Cordoba, Argentina
Edited by: Maria Teresa Herdeiro, University of Aveiro, Portugal
OpenAccessLink https://doaj.org/article/36325d047c62428eaf522ed2ba1f621d
PMID 38549668
PQID 3022569012
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_36325d047c62428eaf522ed2ba1f621d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10976946
proquest_miscellaneous_3022569012
pubmed_primary_38549668
crossref_citationtrail_10_3389_fphar_2024_1340255
crossref_primary_10_3389_fphar_2024_1340255
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-03-13
PublicationDateYYYYMMDD 2024-03-13
PublicationDate_xml – month: 03
  year: 2024
  text: 2024-03-13
  day: 13
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References (B82) 2022
Li (B45) 2017; 47
Lasmar (B44) 2009; 64
Kocks (B42) 2018; 28
Hernandez (B34) 2018; 13
Bukstein (B12) 2007; 20
McMahon (B52) 2000; 9
Vervloet (B88) 2022; 32
Gusi (B31) 2014; 81
Papi (B62) 2018; 6
Smith (B76) 2009; 46
van Boven (B85) 2015; 25
Dima (B21) 2019; 54
Reddel (B70) 2009; 180
Camargo (B13) 2007; 64
Singer (B75) 2003
Sousa-Pinto (B78) 2023
B30
Hale (B33) 2023; 11
B1
Boutopoulou (B10) 2018; 6
Engelkes (B23) 2015; 45
Mayoral (B51) 2021; 30
O’byrne (B59) 2001; 164
Normansell (B58) 2017; 23
Yildiz (B97) 2014; 59
Lizano-Barrantes (B47) 2022; 19
Azzi (B6) 2017; 27
Herndon (B35) 2012; 30
Ramos-Goñi (B67) 2020; 38
Ramsahai (B68) 2019; 199
Vrijens (B90) 2012; 73
Giraud (B28) 2011; 105
Chowdhury (B16) 2021; 30
Mattke (B50) 2010; 47
Quint (B64) 2022; 10
Santos (B73) 2008; 34
Bercedo Sanz (B9) 2022; 97
Bårnes (B8) 2015; 60
Braido (B11) 2016; 4
Gillette (B27) 2016; 16
de Benedictis (B17) 2017; 52
Delea (B18) 2008; 24
Ramos-Goñi (B66) 2024
Chowdhury (B15) 2010; 362
Dima (B20) 2017; 32
Hyland (B36) 2012; 21
Lizano-Barrantes (B48)
Stern (B80) 2006; 97
García-Marcos (B26) 2023; 11
Sundell (B81) 2011; 5
Wille (B94) 2010; 19
Krishnan (B43) 2012; 129
Wiebe (B92) 2003; 56
Song (B77) 2022; 12
Ravens-Sieberer (B69) 2010; 19
Noorduyn (B57) 2022; 8
Almomani (B4) 2021; 56
Oussedik (B61) 2017; 11
(B56) 2020
Vrijens (B91) 2016; 4
Elkout (B22) 2012; 7
Rohan (B72) 2010; 35
Hagmolen of ten Have (B32) 2008; 45
Yeatts (B96) 2010; 47
Balkrishnan (B7) 2000; 37
Usmani (B84) 2018; 19
Williams (B95) 2011; 128
Zhang (B98) 2022; 10
Jenkins (B37) 2022; 10
Vazquez-Ortiz (B86) 2020; 75
Montuschi (B55) 2011; 16
Vervloet (B87) 2020; 8
Everhart (B24) 2009; 75
Osman (B60) 1999; 36
(B29) 2017
Maricoto (B49) 2020; 37
Juniper (B40); 99
Adams (B3) 2005; 2008
Johnson (B38) 2017; 5
Souverein (B79) 2017; 5
Monteiro (B54) 2022
Wild (B93) 2005; 8
Roche (B71) 2022
Tiggelman (B83) 2015; 24
Juniper (B39) 2006
Asher (B5) 2021; 398
Lizano-Barrantes (B46); 19
McNally (B53) 2009; 46
Exarchos (B25) 2022; 22
Juniper (B41); 99
Chongmelaxme (B14) 2020; 60
Ramos-Goñi (B65) 2018; 21
von Mutius (B89) 2020; 396
Pauwels (B63) 2003; 361
Silva (B74) 2015; 15
Adams, N. (B2) 2005
Dima (B19) 2016; 4
References_xml – volume: 30
  start-page: 3127
  year: 2021
  ident: B51
  article-title: Smartphone App for monitoring Asthma in children and adolescents
  publication-title: Qual. Life Res.
  doi: 10.1007/s11136-020-02706-z
– volume: 97
  start-page: 402
  year: 2006
  ident: B80
  article-title: Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data
  publication-title: Ann. Allergy Asthma Immunol.
  doi: 10.1016/S1081-1206(10)60808-3
– volume-title: Cochrane Database of systematic reviews
  year: 2005
  ident: B2
  article-title: Fluticasone versus placebo for chronic asthma in adults and children
– volume: 8
  start-page: 00140-2022
  year: 2022
  ident: B57
  article-title: SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
  publication-title: ERJ Open Res.
  doi: 10.1183/23120541.00140-2022
– volume: 128
  start-page: 1185
  year: 2011
  ident: B95
  article-title: Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence
  publication-title: J. Allergy Clin. Immunol.
  doi: 10.1016/j.jaci.2011.09.011
– volume: 56
  start-page: 52
  year: 2003
  ident: B92
  article-title: Comparative responsiveness of generic and specific quality-of-life instruments
  publication-title: J. Clin. Epidemiol.
  doi: 10.1016/s0895-4356(02)00537-1
– volume: 19
  start-page: 875
  year: 2010
  ident: B94
  article-title: Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
  publication-title: Qual. Life Res.
  doi: 10.1007/s11136-010-9648-y
– volume: 15
  start-page: 499
  year: 2015
  ident: B74
  article-title: Quality of life in pediatric asthma patients and their parents: a meta-analysis on 20 years of research
  publication-title: Expert Rev. Pharmacoecon Outcomes Res.
  doi: 10.1586/14737167.2015.1008459
– volume: 99
  start-page: 553
  ident: B41
  article-title: Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
  publication-title: Respir. Med.
  doi: 10.1016/j.rmed.2004.10.008
– volume: 19
  start-page: 2591
  year: 2022
  ident: B47
  article-title: The inhaler technique questionnaire (InTeQ): development and validation of a brief patient-reported measure
  publication-title: Int. J. Environ. Res. Public Health
  doi: 10.3390/ijerph19052591
– volume: 4
  start-page: 802
  year: 2016
  ident: B91
  article-title: What we mean when we talk about adherence in respiratory medicine
  publication-title: J. Aller Cl. Imm-Pract.
  doi: 10.1016/j.jaip.2016.05.019
– volume: 11
  start-page: 591
  year: 2023
  ident: B33
  article-title: Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial
  publication-title: Lancet Respir. Med.
  doi: 10.1016/S2213-2600(22)00534-3
– volume: 9
  start-page: 293
  year: 2000
  ident: B52
  article-title: Continuity of prescribing with inhaled corticosteroids and control of asthma
  publication-title: Pharmacoepidemiol Drug Saf.
  doi: 10.1002/1099-1557(200007/08)9:4<293::AID-PDS502>3.0.CO;2-S
– volume: 32
  start-page: 1288
  year: 2017
  ident: B20
  article-title: Measuring medication adherence in asthma: development of a novel self-report tool
  publication-title: Psychol. Health
  doi: 10.1080/08870446.2017.1290248
– start-page: S1
  year: 2022
  ident: B82
  publication-title: Int J Tuberc Lung Dis
– volume: 46
  start-page: 234
  year: 2009
  ident: B76
  article-title: Evaluation of risk factors and health outcomes among persons with asthma
  publication-title: J. Asthma
  doi: 10.1080/02770900802627294
– year: 2024
  ident: B66
  article-title: Preference-based assessments accounting for unobservable preference heterogeneity and evaluating alternative anchoring approaches to estimate country-specific EQ-5D-Y value sets: a case study using Spanish preference data
– ident: B30
– volume: 19
  start-page: 798
  ident: B46
  article-title: Inhaler Technique Questionnaire (InTeQ) in pediatric patients with asthma
  publication-title: World J. Pediatr.
  doi: 10.1007/s12519-023-00695-w
– volume: 36
  start-page: 449
  year: 1999
  ident: B60
  article-title: Requests for repeat medication prescriptions and frequency of acute episodes in asthma patients
  publication-title: J. Asthma
  doi: 10.3109/02770909909087287
– volume: 8
  start-page: 94
  year: 2005
  ident: B93
  article-title: Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2005.04054.x
– volume-title: Global strategy for asthma management and prevention
  year: 2017
  ident: B29
– volume: 4
  start-page: 823
  year: 2016
  ident: B11
  article-title: “Trying, but failing” — the role of inhaler technique and mode of delivery in respiratory medication adherence
  publication-title: J. Allergy Clin. Immunol. Prac.
  doi: 10.1016/j.jaip.2016.03.002
– volume: 16
  start-page: 605
  year: 2016
  ident: B27
  article-title: Inhaler technique in children with asthma: a systematic review
  publication-title: Acad. Pediatr.
  doi: 10.1016/j.acap.2016.04.006
– volume: 99
  start-page: 553
  ident: B40
  article-title: Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
  publication-title: Respir. Med.
  doi: 10.1016/j.rmed.2004.10.008
– volume: 28
  start-page: 43
  year: 2018
  ident: B42
  article-title: Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD
  publication-title: NPJ Prim. Care Respir. Med.
  doi: 10.1038/s41533-018-0110-x
– volume: 5
  start-page: 195
  year: 2011
  ident: B81
  article-title: Quality of life in adolescents with asthma, during the transition period from child to adult
  publication-title: Clin. Respir. J.
  doi: 10.1111/j.1752-699X.2010.00218.x
– ident: B1
– volume: 362
  start-page: 1169
  year: 2010
  ident: B15
  article-title: The FDA and safe use of long-acting beta-agonists in the treatment of asthma
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp1002074
– volume: 21
  start-page: 405
  year: 2012
  ident: B36
  article-title: Frequency of non-asthma GP visits predicts asthma exacerbations: an observational study in general practice
  publication-title: Prim. Care Respir. J.
  doi: 10.4104/pcrj.2012.00061
– start-page: 106949
  year: 2022
  ident: B71
  article-title: The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: a systematic review
  publication-title: Respir. Med.
  doi: 10.1016/j.rmed.2022.106949
– volume: 81
  start-page: 212
  year: 2014
  ident: B31
  article-title: Validity and reliability of the Spanish EQ-5D-Y Proxy version
  publication-title: An Pediatr (Engl Ed).
  doi: 10.1016/j.anpedi.2013.11.028
– volume: 59
  start-page: 223
  year: 2014
  ident: B97
  article-title: Importance of inhaler device use status in the control of asthma in adults: the asthma inhaler treatment study
  publication-title: Respir. Care
  doi: 10.4187/respcare.02478
– volume: 6
  start-page: 232
  year: 2018
  ident: B10
  article-title: Interventions on adherence to treatment in children with severe asthma: a systematic review
  publication-title: Front. Pediatr.
  doi: 10.3389/fped.2018.00232
– volume: 19
  start-page: 10
  year: 2018
  ident: B84
  article-title: Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes
  publication-title: Respir. Res.
  doi: 10.1186/s12931-017-0710-y
– volume: 13
  start-page: 02026244
  year: 2018
  ident: B34
  article-title: Impact of asthma on women and men: comparison with the general population using the eq-5d-5l questionnaire
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0202624
– volume: 396
  start-page: 854
  year: 2020
  ident: B89
  article-title: Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31861-4
– volume: 73
  start-page: 691
  year: 2012
  ident: B90
  article-title: A new taxonomy for describing and defining adherence to medications
  publication-title: Br. J. Clin. Pharmacol.
  doi: 10.1111/j.1365-2125.2012.04167.x
– volume: 22
  start-page: 254
  year: 2022
  ident: B25
  article-title: Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study
  publication-title: BMC Pulm. Med.
  doi: 10.1186/s12890-022-02049-0
– volume: 10
  start-page: 963
  year: 2022
  ident: B37
  article-title: Personalized treatment of asthma: the importance of sex and gender differences
  publication-title: J. Allergy Clin. Immunol. Pract.
  doi: 10.1016/j.jaip.2022.02.002
– volume-title: Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study
  ident: B48
  doi: 10.3389/fphar.2024.1340255
– volume: 24
  start-page: 3435
  year: 2008
  ident: B18
  article-title: Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs
  publication-title: Curr. Med. Res. Opin.
  doi: 10.1185/03007990802557344
– volume: 2008
  start-page: 2008
  year: 2005
  ident: B3
  article-title: Beclomethasone versus placebo for chronic asthma
  publication-title: Cochrane Database Syst. Rev.
  doi: 10.1002/14651858.cd002738.pub2
– volume: 37
  start-page: 511
  year: 2000
  ident: B7
  article-title: Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments
  publication-title: J. Asthma
  doi: 10.3109/02770900009055478
– volume: 4
  start-page: 868
  year: 2016
  ident: B19
  article-title: Mapping the asthma care process: implications for research and practice
  publication-title: J. Allergy Clin. Immunol. Prac.
  doi: 10.1016/j.jaip.2016.04.020
– volume: 20
  start-page: 211
  year: 2007
  ident: B12
  article-title: Outcomes among a young population of pediatric asthma patients using controller therapies: results from a retrospective database analysis
  publication-title: Pediatr. Asthma Allergy Immunol.
  doi: 10.1089/pai.2006.024
– volume: 52
  start-page: 129
  year: 2017
  ident: B17
  article-title: Asthma in adolescence: is there any news?
  publication-title: Pediatr. Pulmonol.
  doi: 10.1002/ppul.23498
– volume: 32
  start-page: 43
  year: 2022
  ident: B88
  article-title: Understanding relationships between asthma medication use and outcomes in a SABINA primary care database study
  publication-title: NPJ Prim. Care Respir. Med.
  doi: 10.1038/s41533-022-00310-x
– volume: 6
  start-page: 1989
  year: 2018
  ident: B62
  article-title: Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma
  publication-title: J. Allergy Clin. Immunol. Pract.
  doi: 10.1016/j.jaip.2018.03.008
– volume: 12
  start-page: 04052
  year: 2022
  ident: B77
  article-title: Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study
  publication-title: J. Glob. Health
  doi: 10.7189/jogh.12.04052
– volume: 25
  start-page: 15046
  year: 2015
  ident: B85
  article-title: Towards tailored and targeted adherence assessment to optimise asthma management
  publication-title: NPJ Prim. Care Respir. Med.
  doi: 10.1038/npjpcrm.2015.46
– volume: 60
  start-page: 669
  year: 2020
  ident: B14
  article-title: Association between adherence and severe asthma exacerbation: a systematic review and meta-analysis
  publication-title: J. Am. Pharm. Assoc.
  doi: 10.1016/j.japh.2020.02.010
– volume: 56
  start-page: 866
  year: 2021
  ident: B4
  article-title: Predictors of proper inhaler technique and asthma control in pediatric patients with asthma
  publication-title: Pediatr. Pulmonol.
  doi: 10.1002/ppul.25263
– volume-title: Applied longitudinal data analysis: modeling change and event occurrence
  year: 2003
  ident: B75
  doi: 10.1093/acprof:oso/9780195152968.001.0001
– volume: 361
  start-page: 1071
  year: 2003
  ident: B63
  article-title: Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)12891-7
– volume: 47
  start-page: 323
  year: 2010
  ident: B50
  article-title: Anti-inflammatory medication adherence and cost and utilization of asthma care in a commercially insured population
  publication-title: J. Asthma
  doi: 10.3109/02770900903497196
– volume: 38
  start-page: 653
  year: 2020
  ident: B67
  article-title: International valuation protocol for the EQ-5D-Y-3L
  publication-title: Pharmacoeconomics
  doi: 10.1007/s40273-020-00909-3
– volume: 21
  start-page: 596
  year: 2018
  ident: B65
  article-title: Handling data quality issues to estimate the Spanish EQ-5D-5L value set using a hybrid interval regression approach
  publication-title: Value Health
  doi: 10.1016/j.jval.2017.10.023
– start-page: S2531
  year: 2023
  ident: B78
  article-title: Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: a MASK-air study
  publication-title: Pulmonology
  doi: 10.1016/j.pulmoe.2023.07.004
– volume: 23
  start-page: 53
  year: 2017
  ident: B58
  article-title: Interventions to improve inhaler technique and adherence to inhaled corticosteroids in children with asthma
  publication-title: Paediatr. Respir. Rev.
  doi: 10.1016/j.prrv.2017.03.014
– volume: 199
  start-page: 423
  year: 2019
  ident: B68
  article-title: Mechanisms and management of asthma exacerbations
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.201810-1931CI
– start-page: 191
  year: 2022
  ident: B54
  article-title: Determining factors associated with inhaled therapy adherence on asthma and COPD: a systematic review and meta-analysis of the global literature
  publication-title: Respir. Med.
– volume: 45
  start-page: 396
  year: 2015
  ident: B23
  article-title: Medication adherence and the risk of severe asthma exacerbations: a systematic review
  publication-title: Eur. Respir. J.
  doi: 10.1183/09031936.00075614
– volume: 398
  start-page: 1569
  year: 2021
  ident: B5
  article-title: Worldwide trends in the burden of asthma symptoms in school-aged children: global Asthma Network Phase I cross-sectional study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)01450-1
– volume: 180
  start-page: 59
  year: 2009
  ident: B70
  article-title: An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.200801-060ST
– volume: 7
  start-page: e39130
  year: 2012
  ident: B22
  article-title: Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0039130
– volume: 105
  start-page: 1815
  year: 2011
  ident: B28
  article-title: Inhaler technique and asthma: feasability and acceptability of training by pharmacists
  publication-title: Respir. Med.
  doi: 10.1016/j.rmed.2011.07.004
– volume-title: 2020 focused updates to the asthma management guidelines
  year: 2020
  ident: B56
– volume: 30
  start-page: 210067
  year: 2021
  ident: B16
  article-title: Sex and gender in asthma
  publication-title: Eur. Respir. Rev.
  doi: 10.1183/16000617.0067-2021
– volume: 47
  start-page: 383
  year: 2017
  ident: B45
  article-title: Determinants of longitudinal health-related quality-of-life change in children with asthma from low-income families: a report from the PROMIS® Pediatric Asthma Study
  publication-title: Clin. Exp. Allergy
  doi: 10.1111/cea.12827
– volume: 75
  start-page: 1850
  year: 2020
  ident: B86
  article-title: Understanding the challenges faced by adolescents and young adults with allergic conditions: a systematic review
  publication-title: Allergy
  doi: 10.1111/all.14258
– volume: 27
  start-page: 29
  year: 2017
  ident: B6
  article-title: Practice makes perfect: self-reported adherence a positive marker of inhaler technique maintenance
  publication-title: Prim. Care Respir. J.
  doi: 10.1038/s41533-017-0031-0
– volume: 10
  start-page: 823399
  year: 2022
  ident: B98
  article-title: The burden of childhood asthma by age Group, 1990-2019: a systematic analysis of global burden of disease 2019 data
  publication-title: Front. Pediatr.
  doi: 10.3389/fped.2022.823399
– volume: 16
  start-page: 1084
  year: 2011
  ident: B55
  article-title: New perspectives in pharmacological treatment of mild persistent asthma
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2011.09.005
– volume: 19
  start-page: 887
  year: 2010
  ident: B69
  article-title: Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
  publication-title: Qual. Life Res.
  doi: 10.1007/s11136-010-9649-x
– volume: 164
  start-page: 1392
  year: 2001
  ident: B59
  article-title: Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.164.8.2104102
– volume: 46
  start-page: 921
  year: 2009
  ident: B53
  article-title: Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma
  publication-title: J. Asthma
  doi: 10.3109/02770900903229651
– volume: 35
  start-page: 394
  year: 2010
  ident: B72
  article-title: Adherence to pediatric asthma treatment in economically disadvantaged african-american children and adolescents: an application of growth curve analysis
  publication-title: J. Pediatr. Psychol.
  doi: 10.1093/jpepsy/jsp074
– volume: 54
  start-page: 1900901
  year: 2019
  ident: B21
  article-title: Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study
  publication-title: Eur. Respir. J.
  doi: 10.1183/13993003.00901-2019
– volume: 75
  start-page: 162
  year: 2009
  ident: B24
  article-title: Asthma severity and child quality of life in pediatric asthma: a systematic review
  publication-title: Patient Educ. Couns.
  doi: 10.1016/j.pec.2008.10.001
– volume: 37
  start-page: 605
  year: 2020
  ident: B49
  article-title: Assessment of poor inhaler technique in older patients with asthma or copd: a predictive tool for clinical risk and inhaler performance
  publication-title: Drugs Aging
  doi: 10.1007/s40266-020-00779-6
– volume: 8
  start-page: 626
  year: 2020
  ident: B87
  article-title: The relationship between real-world inhaled corticosteroid adherence and asthma outcomes: a multilevel approach
  publication-title: J. Allergy Clin. Immunol. Pract.
  doi: 10.1016/j.jaip.2019.09.003
– volume: 5
  start-page: 448
  year: 2017
  ident: B79
  article-title: Inhaled corticosteroid adherence patterns in a longitudinal asthma cohort
  publication-title: J. Allergy Clin. Immunol. Pract.
  doi: 10.1016/j.jaip.2016.09.022
– volume: 10
  start-page: 2297
  year: 2022
  ident: B64
  article-title: Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from europe and north America
  publication-title: J. Allergy Clin. Immunol. Pract.
  doi: 10.1016/j.jaip.2022.02.047
– volume: 47
  start-page: 295
  year: 2010
  ident: B96
  article-title: Construction of the pediatric asthma impact scale (PAIS) for the patient-reported outcomes measurement information System (PROMIS)
  publication-title: J. Asthma
  doi: 10.3109/02770900903426997
– volume: 60
  start-page: 455
  year: 2015
  ident: B8
  article-title: Asthma and adherence to inhaled corticosteroids: current status and future perspectives
  publication-title: Respir. Care
  doi: 10.4187/respcare.03200
– volume: 11
  start-page: 1285
  year: 2017
  ident: B61
  article-title: Accountability: a missing construct in models of adherence behavior and in clinical practice
  publication-title: Patient Prefer Adherence
  doi: 10.2147/PPA.S135895
– volume: 11
  start-page: e218
  year: 2023
  ident: B26
  article-title: Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study
  publication-title: Lancet Glob. Health
  doi: 10.1016/S2214-109X(22)00506-X
– volume: 45
  start-page: 67
  year: 2008
  ident: B32
  article-title: Assessment of inhalation technique in children in general practice: increased risk of incorrect performance with new device
  publication-title: J. Asthma
  doi: 10.1080/02770900701815834
– volume: 64
  start-page: 1054
  year: 2007
  ident: B13
  article-title: Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan
  publication-title: Am. J. Health Syst. Pharm.
  doi: 10.2146/ajhp060256
– volume: 30
  start-page: 397
  year: 2012
  ident: B35
  article-title: Anti-inflammatory medication adherence, healthcare utilization and expenditures among medicaid and children’s health insurance program enrollees with asthma
  publication-title: Pharmacoeconomics
  doi: 10.2165/11586660-000000000-00000
– start-page: 616
  year: 2006
  ident: B39
  article-title: Identifying ‘ well-controlled ’ and ‘ not well-controlled ’ asthma using the Asthma Control Questionnaire
  publication-title: Respir. Med.
  doi: 10.1016/j.rmed.2005.08.012
– volume: 24
  start-page: 2067
  year: 2015
  ident: B83
  article-title: Longitudinal associations between asthma control, medication adherence, and quality of life among adolescents: results from a cross-lagged analysis
  publication-title: Qual. Life Res.
  doi: 10.1007/s11136-015-0945-3
– volume: 97
  start-page: 161
  year: 2022
  ident: B9
  article-title: Prevalence and temporal evolution of asthma symptoms in Spain. Global Asthma Network (GAN) study
  publication-title: An Pediatr (Engl Ed).
  doi: 10.1016/j.anpede.2021.10.005
– volume: 34
  start-page: 995
  year: 2008
  ident: B73
  article-title: Predictors of adherence to treatment in patients with severe asthma treated at a referral center in Bahia, Brazil
  publication-title: J. Bras. Pneumol.
  doi: 10.1590/s1806-37132008001200003
– volume: 5
  start-page: 1663
  year: 2017
  ident: B38
  article-title: Stability of asthma symptom control in a longitudinal study of mild-moderate asthmatics
  publication-title: J. Allergy Clin. Immunol. Pract.
  doi: 10.1016/j.jaip.2017.04.006
– volume: 64
  start-page: 784
  year: 2009
  ident: B44
  article-title: Adherence rate to inhaled corticosteroids and their impact on asthma control
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2008.01877.x
– volume: 129
  start-page: 112
  year: 2012
  ident: B43
  article-title: Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial
  publication-title: J. Allergy Clin. Immunol.
  doi: 10.1016/j.jaci.2011.10.030
SSID ssj0000399364
Score 2.3581443
Snippet Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based...
We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based maintenance...
Introduction: We aimed to evaluate the longitudinal relationships, both at between- and within-person levels, that adherence to inhaled corticosteroid-based...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1340255
SubjectTerms adherence
asthma outcomes
asthma symptom control
health-related quality of life
inhalation technique
pediatric asthma
Pharmacology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb5VAEN-Ynnoxav1ArVkT04vFsh8s4K01NtVE00Ob9EZ22dnQpIUXgUP_-84Aj75njF4MJ2CBzczszm_CzG8Y-wBZlggbdIzozcVaSIhtDlXsZJalTkhfjcmYP36as0v9_Sq92mj1RTlhEz3wJLgjZZRMfaKziioZcrABEQN46awIRgpPuy-6sY1gatyDye8aPVXJYBRWHIVVbYn_U-pPQmlC0lueaCTs_xPK_D1ZcsP7nD5hj2fYyI-n6T5lj6B5xg7OJ97pu0N-8VBG1R3yA37-wEh9t8eGb2MtJG8DXxLLufX1VOrHbeP5dVPbKS2OL7SuHE9s19e3lrdDj6YJHb1ite7uwWdS1u4zt_ympc5Hg6cuW3wkrX3OLk-_Xnw5i-d-C3GFQXIfF0RHFgpvM4siFkkwPgENKkgRglEawKW4GxZgwCSZdTpPAwJO8N5bPFL1gu00bQOvGK-oqAEQjfm80BKMc0J4W3kbVOEwxIqYWMu-rGYycuqJcVNiUEL6Kkd9laSvctZXxD4uz6wmKo6_jj4hlS4jiUZ7vIDGVc7GVf7LuCL2fm0QJS47-pdiG2iHrlSIfVJq5iUj9nIykOVTKseg25g8YvmW6WzNZftOc12P1N6UD2AKbV7_j9m_YbskEcqYE-ot2-l_DbCPEKp378bVcg-C_B22
  priority: 102
  providerName: Directory of Open Access Journals
Title Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study
URI https://www.ncbi.nlm.nih.gov/pubmed/38549668
https://www.proquest.com/docview/3022569012
https://pubmed.ncbi.nlm.nih.gov/PMC10976946
https://doaj.org/article/36325d047c62428eaf522ed2ba1f621d
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: KQ8
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: DIK
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1663-9812
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0000399364
  issn: 1663-9812
  databaseCode: M48
  dateStart: 20101201
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db5RAEN_Umpi-GL-larMmpi-Wyn6wgIkxamyqSU0feknfyMLuliYnnAckvf_emQWuPdManoBlgZ3Znd_AzG8IeWeTJGLayRDQWxFKxm2oU1uGBU-SuGDclD4Y8-SXOp7Jn-fx-RaZyh2NA9je6tphPanZcn549Wf1GSb8J_Q4wd5-cItKI7Unl4dMSATJ98h9sEwctfxkhPt-ZUZr7BmlGBjaMAPjNuTR3NHNDnkgUnCgFBKx3jBbnt3_Nkj6b2TlDVN19Ig8HDEm_TIoxWOyZesnZP90IKleHdCz65yr9oDu09Nr-urVU9L_8ImTtHF0HYVOtamGvECqa0Mv60oPMXR0zQFLYUe3XfVb06bvQI9ti10splIgdGRwbT9STecNlknqDZbkop7h9hmZHX0_-3YcjsUZwhI86i7MkLvMZUYnmnPLIqdMZKUVjjPnlJDWFjEsnZlVVkWJLmQaO0Cn1hijYYvFc7JdN7V9SWiJGRAWoJtJM8mtKgrGjC6NdiIrwB8LCJvGPi9H5nIsoDHPwYNB0eVedDmKLh9FF5D362sWA2_Hf1t_RZGuWyLntj_QLC_ycQrnQgkem0gmJebUpFY7wK7W8EIzpzgzAXk7KUQOcxR_vOjaNn2bCwBKMVb-4gF5MSjI-laTggUk3VCdjWfZPFNfVp4HHIMHVCbV7p2dviI7-JoYM8fEa7LdLXv7BkBUV-z5jw97fn78Be1vHG4
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+treatment+adherence+and+inhalation+technique+on+asthma+outcomes+of+pediatric+patients%3A+a+longitudinal+study&rft.jtitle=Frontiers+in+pharmacology&rft.au=Lizano-Barrantes%2C+Catalina&rft.au=Garin%2C+Olatz&rft.au=Mayoral%2C+Karina&rft.au=Dima%2C+Alexandra+L&rft.date=2024-03-13&rft.issn=1663-9812&rft.eissn=1663-9812&rft.volume=15&rft.spage=1340255&rft_id=info:doi/10.3389%2Ffphar.2024.1340255&rft_id=info%3Apmid%2F38549668&rft.externalDocID=38549668
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon